array(40) {
  [0]=>
  string(4) "1800"
  ["article_id"]=>
  string(4) "1800"
  [1]=>
  string(74) "How Using Medical Adhesives Gives Your Products a Competitive Advantage"
  ["article_title"]=>
  string(74) "How Using Medical Adhesives Gives Your Products a Competitive Advantage"
  [2]=>
  string(150) "Adhesives are ubiquitous. With virtually limitless applications, the retail stick-to skin market is a good choice for companies looking to expand thei"
  ["short_description"]=>
  string(150) "Adhesives are ubiquitous. With virtually limitless applications, the retail stick-to skin market is a good choice for companies looking to expand thei"
  [3]=>
  string(566) "
Adhesives are ubiquitous. With virtually limitless applications, the retail stick-to skin market is a good choice for companies looking to expand their product offerings. 
&#nl
The post How Using Medical Adhesives Gives Your Products a Competitive Advantage appeared first on MedTech Intelligence.
&#nl"
  ["description"]=>
  string(566) "
Adhesives are ubiquitous. With virtually limitless applications, the retail stick-to skin market is a good choice for companies looking to expand their product offerings. 
&#nl
The post How Using Medical Adhesives Gives Your Products a Competitive Advantage appeared first on MedTech Intelligence.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "98"
  ["rss_id"]=>
  string(2) "98"
  [14]=>
  string(121) "https://www.medtechintelligence.com/news_article/how-using-medical-adhesives-gives-your-products-a-competitive-advantage/"
  ["blog_url"]=>
  string(121) "https://www.medtechintelligence.com/news_article/how-using-medical-adhesives-gives-your-products-a-competitive-advantage/"
  [15]=>
  string(19) "2019-03-12 20:04:56"
  ["add_date"]=>
  string(19) "2019-03-12 20:04:56"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-03-29 16:07:46"
  ["create_at"]=>
  string(19) "2019-03-29 16:07:46"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "4879"
  ["article_id"]=>
  string(4) "4879"
  [1]=>
  string(48) "Overview of the New EU Clinical Trial Regulation"
  ["article_title"]=>
  string(48) "Overview of the New EU Clinical Trial Regulation"
  [2]=>
  string(150) "The new EU Clinical Trial Regulation (536/2014) will replace the European Clinical Trials Directive (2001/20/EC). It was originally due to come into e"
  ["short_description"]=>
  string(150) "The new EU Clinical Trial Regulation (536/2014) will replace the European Clinical Trials Directive (2001/20/EC). It was originally due to come into e"
  [3]=>
  string(500) "The new EU Clinical Trial Regulation (536/2014) will replace the European Clinical Trials Directive (2001/20/EC). It was originally due to come into effect in 2016, however implementation has been delayed until the new portal and clinical trial database have been completed and audited. Key aims of the new regulation are to harmonise procedures for carrying out clinical trials across the EU and to simplify the clinical trial approval dossier by submitting clinical trial information through a s..."
  ["description"]=>
  string(500) "The new EU Clinical Trial Regulation (536/2014) will replace the European Clinical Trials Directive (2001/20/EC). It was originally due to come into effect in 2016, however implementation has been delayed until the new portal and clinical trial database have been completed and audited. Key aims of the new regulation are to harmonise procedures for carrying out clinical trials across the EU and to simplify the clinical trial approval dossier by submitting clinical trial information through a s..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(80) "https://www.pharmiweb.com/event/overview-of-the-new-eu-clinical-trial-regulation"
  ["blog_url"]=>
  string(80) "https://www.pharmiweb.com/event/overview-of-the-new-eu-clinical-trial-regulation"
  [15]=>
  string(19) "2019-03-12 16:09:23"
  ["add_date"]=>
  string(19) "2019-03-12 16:09:23"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-09-27 14:12:08"
  ["create_at"]=>
  string(19) "2019-09-27 14:12:08"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1848"
  ["article_id"]=>
  string(4) "1848"
  [1]=>
  string(72) "Registration opens for SMi's 4th Pre-filled Syringes West Coast 2019"
  ["article_title"]=>
  string(72) "Registration opens for SMi's 4th Pre-filled Syringes West Coast 2019"
  [2]=>
  string(150) "Building on last year’s success SMi Group are proud to present the 4th Pre-filled Syringes West Coast 2019 Conference and exhibition in CA, USA."
  ["short_description"]=>
  string(150) "Building on last year’s success SMi Group are proud to present the 4th Pre-filled Syringes West Coast 2019 Conference and exhibition in CA, USA."
  [3]=>
  string(525) "Building on last year’s success SMi Group are proud to present the 4th Pre-filled Syringes West Coast 2019 Conference and exhibition in CA, USA.Conference Overview:Pre-Filled Syringes West Coast will gather a global audience of medical device experts and PFS industry leaders to discuss new developments and showcase the latest and advancements, keeping you at the forefront of a booming industry.Join us June 3rd-4th 2019, in San Diego along with one post-conference workshop: The Secrets to...&#nl&#nlSource: RealWire"
  ["description"]=>
  string(525) "Building on last year’s success SMi Group are proud to present the 4th Pre-filled Syringes West Coast 2019 Conference and exhibition in CA, USA.Conference Overview:Pre-Filled Syringes West Coast will gather a global audience of medical device experts and PFS industry leaders to discuss new developments and showcase the latest and advancements, keeping you at the forefront of a booming industry.Join us June 3rd-4th 2019, in San Diego along with one post-conference workshop: The Secrets to...&#nl&#nlSource: RealWire"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "64"
  ["rss_id"]=>
  string(2) "64"
  [14]=>
  string(100) "http://www.realwire.com/releases/Registration-opens-for-SMis-4th-Pre-filled-Syringes-West-Coast-2019"
  ["blog_url"]=>
  string(100) "http://www.realwire.com/releases/Registration-opens-for-SMis-4th-Pre-filled-Syringes-West-Coast-2019"
  [15]=>
  string(19) "2019-03-12 16:00:00"
  ["add_date"]=>
  string(19) "2019-03-12 16:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-04-22 13:42:54"
  ["create_at"]=>
  string(19) "2019-04-22 13:42:54"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1945"
  ["article_id"]=>
  string(4) "1945"
  [1]=>
  string(108) "Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine"
  ["article_title"]=>
  string(108) "Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine"
  [2]=>
  string(150) "DUBLIN, March 11, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted the comp"
  ["short_description"]=>
  string(150) "DUBLIN, March 11, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted the comp"
  [3]=>
  string(251) "DUBLIN, March 11, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's New Drug Application (NDA) for ubrogepant for the acute treatment of migraine in adults...."
  ["description"]=>
  string(251) "DUBLIN, March 11, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's New Drug Application (NDA) for ubrogepant for the acute treatment of migraine in adults...."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "9"
  ["rss_id"]=>
  string(1) "9"
  [14]=>
  string(200) "https://www.drugs.com/nda/ubrogepant_190311.html?utm_source=ddc&utm_medium=rss&utm_campaign=Allergan+Announces+FDA+Acceptance+of+New+Drug+Application+for+Ubrogepant+for+the+Acute+Treatment+of+Migraine"
  ["blog_url"]=>
  string(200) "https://www.drugs.com/nda/ubrogepant_190311.html?utm_source=ddc&utm_medium=rss&utm_campaign=Allergan+Announces+FDA+Acceptance+of+New+Drug+Application+for+Ubrogepant+for+the+Acute+Treatment+of+Migraine"
  [15]=>
  string(19) "2019-03-12 07:03:59"
  ["add_date"]=>
  string(19) "2019-03-12 07:03:59"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:51"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:51"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2019"
  ["article_id"]=>
  string(4) "2019"
  [1]=>
  string(173) "Trevena Announces Publication of APOLLO-1 Results in The Journal of Pain Research Highlighting Oliceridine’s Potential for Management of Moderate-to-Severe Acute Pain"
  ["article_title"]=>
  string(173) "Trevena Announces Publication of APOLLO-1 Results in The Journal of Pain Research Highlighting Oliceridine’s Potential for Management of Moderate-to-Severe Acute Pain"
  [2]=>
  string(150) "March 11, 2019 -- Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical company focused on the development and commercialization of innovative treatment o"
  ["short_description"]=>
  string(150) "March 11, 2019 -- Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical company focused on the development and commercialization of innovative treatment o"
  [3]=>
  string(252) "March 11, 2019 -- Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical company focused on the development and commercialization of innovative treatment options that target and treat diseases affecting the central nervous system, or CNS, today announced..."
  ["description"]=>
  string(252) "March 11, 2019 -- Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical company focused on the development and commercialization of innovative treatment options that target and treat diseases affecting the central nervous system, or CNS, today announced..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(300) "https://www.drugs.com/clinical_trials/trevena-announces-publication-apollo-1-results-journal-pain-research-highlighting-oliceridine-s-18089.html?utm_source=ddc&utm_medium=rss&utm_campaign=Trevena+Announces+Publication+of+APOLLO-1+Results+in+The+Journal+of+Pain+Research+Highlighting+Oliceridine%E2%80"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/clinical_trials/trevena-announces-publication-apollo-1-results-journal-pain-research-highlighting-oliceridine-s-18089.html?utm_source=ddc&utm_medium=rss&utm_campaign=Trevena+Announces+Publication+of+APOLLO-1+Results+in+The+Journal+of+Pain+Research+Highlighting+Oliceridine%E2%80"
  [15]=>
  string(19) "2019-03-12 07:03:23"
  ["add_date"]=>
  string(19) "2019-03-12 07:03:23"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:57"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:57"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1801"
  ["article_id"]=>
  string(4) "1801"
  [1]=>
  string(98) "Edwards Lifesciences Makes Strategic Acquisitions of Corvia Medical, Transcatheter Technologies"
  ["article_title"]=>
  string(98) "Edwards Lifesciences Makes Strategic Acquisitions of Corvia Medical, Transcatheter Technologies"
  [2]=>
  string(158) "The strategic acquisitions expand the company’s structural heart disease technologies.&#nlThe post Edwards Lifesciences Makes Strategic Acquisitions of"
  ["short_description"]=>
  string(158) "The strategic acquisitions expand the company’s structural heart disease technologies.&#nlThe post Edwards Lifesciences Makes Strategic Acquisitions of"
  [3]=>
  string(535) "
The strategic acquisitions expand the company’s structural heart disease technologies.
&#nl
The post Edwards Lifesciences Makes Strategic Acquisitions of Corvia Medical, Transcatheter Technologies appeared first on MedTech Intelligence.
&#nl"
  ["description"]=>
  string(535) "
The strategic acquisitions expand the company’s structural heart disease technologies.
&#nl
The post Edwards Lifesciences Makes Strategic Acquisitions of Corvia Medical, Transcatheter Technologies appeared first on MedTech Intelligence.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "98"
  ["rss_id"]=>
  string(2) "98"
  [14]=>
  string(144) "https://www.medtechintelligence.com/news_article/edwards-lifesciences-makes-strategic-acquisitions-in-corvia-medical-transcatheter-technologies/"
  ["blog_url"]=>
  string(144) "https://www.medtechintelligence.com/news_article/edwards-lifesciences-makes-strategic-acquisitions-in-corvia-medical-transcatheter-technologies/"
  [15]=>
  string(19) "2019-03-11 22:07:02"
  ["add_date"]=>
  string(19) "2019-03-11 22:07:02"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-03-29 16:07:46"
  ["create_at"]=>
  string(19) "2019-03-29 16:07:46"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1802"
  ["article_id"]=>
  string(4) "1802"
  [1]=>
  string(68) "An Option for Patients Between Therapy and Major Invasive Surgery"
  ["article_title"]=>
  string(68) "An Option for Patients Between Therapy and Major Invasive Surgery"
  [2]=>
  string(153) "Reparative medicine technology is an option to delay or avoid orthopedic surgery.&#nlThe post An Option for Patients Between Therapy and Major Invasive&n"
  ["short_description"]=>
  string(153) "Reparative medicine technology is an option to delay or avoid orthopedic surgery.&#nlThe post An Option for Patients Between Therapy and Major Invasive&n"
  [3]=>
  string(458) "
Reparative medicine technology is an option to delay or avoid orthopedic surgery.
&#nl
The post An Option for Patients Between Therapy and Major Invasive Surgery appeared first on MedTech Intelligence.
&#nl"
  ["description"]=>
  string(458) "
Reparative medicine technology is an option to delay or avoid orthopedic surgery.
&#nl
The post An Option for Patients Between Therapy and Major Invasive Surgery appeared first on MedTech Intelligence.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "98"
  ["rss_id"]=>
  string(2) "98"
  [14]=>
  string(109) "https://www.medtechintelligence.com/column/an-option-for-patients-between-therapy-and-major-invasive-surgery/"
  ["blog_url"]=>
  string(109) "https://www.medtechintelligence.com/column/an-option-for-patients-between-therapy-and-major-invasive-surgery/"
  [15]=>
  string(19) "2019-03-11 20:00:39"
  ["add_date"]=>
  string(19) "2019-03-11 20:00:39"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-03-29 16:07:46"
  ["create_at"]=>
  string(19) "2019-03-29 16:07:46"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2416"
  ["article_id"]=>
  string(4) "2416"
  [1]=>
  string(96) "23andMe thinks polygenic risk scores are ready for the masses, but experts aren’t so sure"
  ["article_title"]=>
  string(96) "23andMe thinks polygenic risk scores are ready for the masses, but experts aren’t so sure"
  [2]=>
  string(106) "A new genetic test that estimates your risk for diabetes is probably less useful than standing on a scale."
  ["short_description"]=>
  string(106) "A new genetic test that estimates your risk for diabetes is probably less useful than standing on a scale."
  [3]=>
  string(106) "A new genetic test that estimates your risk for diabetes is probably less useful than standing on a scale."
  ["description"]=>
  string(106) "A new genetic test that estimates your risk for diabetes is probably less useful than standing on a scale."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(3) "103"
  ["rss_id"]=>
  string(3) "103"
  [14]=>
  string(130) "https://www.technologyreview.com/s/613095/23andme-thinks-polygenic-risk-scores-are-ready-for-the-masses-but-experts-arent-so-sure/"
  ["blog_url"]=>
  string(130) "https://www.technologyreview.com/s/613095/23andme-thinks-polygenic-risk-scores-are-ready-for-the-masses-but-experts-arent-so-sure/"
  [15]=>
  string(19) "2019-03-09 00:56:00"
  ["add_date"]=>
  string(19) "2019-03-09 00:56:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:42:33"
  ["create_at"]=>
  string(19) "2019-05-09 16:42:33"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1946"
  ["article_id"]=>
  string(4) "1946"
  [1]=>
  string(128) "Foamix Announces FDA Acceptance of New Drug Application for FMX101 Minocycline Foam for the Treatment of Moderate-to-Severe Acne"
  ["article_title"]=>
  string(128) "Foamix Announces FDA Acceptance of New Drug Application for FMX101 Minocycline Foam for the Treatment of Moderate-to-Severe Acne"
  [2]=>
  string(150) "REHOVOT, Israel, and BRIDGEWATER, N.J., March 07, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty phar"
  ["short_description"]=>
  string(150) "REHOVOT, Israel, and BRIDGEWATER, N.J., March 07, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty phar"
  [3]=>
  string(246) "REHOVOT, Israel, and BRIDGEWATER, N.J., March 07, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to..."
  ["description"]=>
  string(246) "REHOVOT, Israel, and BRIDGEWATER, N.J., March 07, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "9"
  ["rss_id"]=>
  string(1) "9"
  [14]=>
  string(216) "https://www.drugs.com/nda/fmx101_190307.html?utm_source=ddc&utm_medium=rss&utm_campaign=Foamix+Announces+FDA+Acceptance+of+New+Drug+Application+for+FMX101+Minocycline+Foam+for+the+Treatment+of+Moderate-to-Severe+Acne"
  ["blog_url"]=>
  string(216) "https://www.drugs.com/nda/fmx101_190307.html?utm_source=ddc&utm_medium=rss&utm_campaign=Foamix+Announces+FDA+Acceptance+of+New+Drug+Application+for+FMX101+Minocycline+Foam+for+the+Treatment+of+Moderate-to-Severe+Acne"
  [15]=>
  string(19) "2019-03-07 08:03:49"
  ["add_date"]=>
  string(19) "2019-03-07 08:03:49"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:51"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:51"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1918"
  ["article_id"]=>
  string(4) "1918"
  [1]=>
  string(143) "American Health Packaging Issues Voluntary Nationwide Recall of Valsartan Tablets Due to the Detection of NDEA (N-Nitrosodiethylamine) Impurity"
  ["article_title"]=>
  string(143) "American Health Packaging Issues Voluntary Nationwide Recall of Valsartan Tablets Due to the Detection of NDEA (N-Nitrosodiethylamine) Impurity"
  [2]=>
  string(150) "Audience:  Consumer, Health Professional, Pharmacy American Health Packaging is voluntarily recalling one lot of Valsartan Tablets, USP, 160 mg to the"
  ["short_description"]=>
  string(150) "Audience:  Consumer, Health Professional, Pharmacy American Health Packaging is voluntarily recalling one lot of Valsartan Tablets, USP, 160 mg to the"
  [3]=>
  string(245) "Audience:  Consumer, Health Professional, Pharmacy American Health Packaging is voluntarily recalling one lot of Valsartan Tablets, USP, 160 mg to the consumer level due to the detection of trace amounts of an unexpected impurity found in the..."
  ["description"]=>
  string(245) "Audience:  Consumer, Health Professional, Pharmacy American Health Packaging is voluntarily recalling one lot of Valsartan Tablets, USP, 160 mg to the consumer level due to the detection of trace amounts of an unexpected impurity found in the..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "7"
  ["rss_id"]=>
  string(1) "7"
  [14]=>
  string(300) "https://www.drugs.com/fda/american-health-packaging-issues-voluntary-nationwide-recall-valsartan-due-detection-ndea-n-14251.html?utm_source=ddc&utm_medium=rss&utm_campaign=American+Health+Packaging+Issues+Voluntary+Nationwide+Recall+of+Valsartan+Tablets+Due+to+the+Detection+of+NDEA+%28N-Nitrosodieth"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/fda/american-health-packaging-issues-voluntary-nationwide-recall-valsartan-due-detection-ndea-n-14251.html?utm_source=ddc&utm_medium=rss&utm_campaign=American+Health+Packaging+Issues+Voluntary+Nationwide+Recall+of+Valsartan+Tablets+Due+to+the+Detection+of+NDEA+%28N-Nitrosodieth"
  [15]=>
  string(19) "2019-03-07 08:00:00"
  ["add_date"]=>
  string(19) "2019-03-07 08:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:50"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:50"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "4540"
  ["article_id"]=>
  string(4) "4540"
  [1]=>
  string(45) "Infectious diseases and clinical microbiology"
  ["article_title"]=>
  string(45) "Infectious diseases and clinical microbiology"
  [2]=>
  string(150) "We invite you to attend an International conference on infectious diseases and clinical microbiology conference regular on September 23-25, 2019 at Lo"
  ["short_description"]=>
  string(150) "We invite you to attend an International conference on infectious diseases and clinical microbiology conference regular on September 23-25, 2019 at Lo"
  [3]=>
  string(503) "We invite you to attend an International conference on infectious diseases and clinical microbiology conference regular on September 23-25, 2019 at London, UK. The main aim is to share and develop knowledge on infectious diseases.&#nlIDCM 2019 provide you an ideal platform to boost your knowledge and will stimulate a creative exchange of ideas and you can learn about a variety of perspectives, both research based and clinical, with newest therapeutic techniques, diagnosis and innovative treatmen..."
  ["description"]=>
  string(503) "We invite you to attend an International conference on infectious diseases and clinical microbiology conference regular on September 23-25, 2019 at London, UK. The main aim is to share and develop knowledge on infectious diseases.&#nlIDCM 2019 provide you an ideal platform to boost your knowledge and will stimulate a creative exchange of ideas and you can learn about a variety of perspectives, both research based and clinical, with newest therapeutic techniques, diagnosis and innovative treatmen..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(77) "https://www.pharmiweb.com/event/infectious-diseases-and-clinical-microbiology"
  ["blog_url"]=>
  string(77) "https://www.pharmiweb.com/event/infectious-diseases-and-clinical-microbiology"
  [15]=>
  string(19) "2019-03-06 15:31:34"
  ["add_date"]=>
  string(19) "2019-03-06 15:31:34"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-09-14 14:32:21"
  ["create_at"]=>
  string(19) "2019-09-14 14:32:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}